Increasing evidence indicates that a single molecular actor can lead to opposite cellular effects depending on the environmental conditions. Indeed oncogenes, receptors, or apoptosis modulators (for example of the Bcl-2 family) can drive cells either to proliferate (or differentiate or migrate) and survive, or to die in a programmed fashion. 1, 2 The balance between these positive and negative signals in individual cells determines their fate, and the resulting number and nature of proliferating/surviving and dying cells subsequently determines the fate of the tissue or organ. Such phenomena are pivotal in physiology, e.g., in development, and are deregulated in pathology leading to cancer.
The recently described "dependence receptor" family seems to fit the above criteria. These receptors, defined by their functional rather than structural similarity, create cellular states of dependence on their respective ligands by inducing or favoring apoptosis when unoccupied by ligand, but inhibiting apoptosis in the presence of ligand. All these receptors appear to be cleaved during apoptosis, most of them by caspases (reviewed by Bredesen et al 3 ) , leading to the release or the exposure of a proapoptotic peptide and creating a positive feedback loop for apoptosis enhancement. Several members are involved in neuronal development and migration or axonal guidance. They include p75 NTR , a low affinity receptor for nerve growth factor, 3 the netrin receptors DCC (deleted in colorectal cancer) and UNC5H, 4-7 the integrin αvβ3, 8 Patch (a receptor for the morphogen Sonic hedgehog), 9 and neogenin. 10 An interesting example of a dependence receptor is given by RET (rearranged during transfection), a receptor tyrosine kinase acting as a coreceptor for the glial cell-derived neurotrophic factor (GDNF). RET induces apoptosis in the absence of ligand, and the addition of GDNF is then sufficient to block RET pro-apoptotic activity. Moreover RET is cleaved in vitro by caspase 3 and the caspase cleavage sites are crucial for RET-induced cell death, probably by allowing the release of a pro-apoptotic fragment. 11 In humans, mutations that inactivate RET lead to Hirschprung's disease (congenital aganglionic megacolon), a developmental defect due to the lack of enteric neurons. 12, 13 In contrast, mutations activating the receptor tyrosine kinase RET lead to multiple endocrine neoplasia type 2, an inherited cancer syndrome. 14 Thus this dependence receptor can play a role as an oncogene as a result of constitutive activation of its kinase activity. 15 Alternatively, some dependence receptors can play a role in cancer as conditional tumor suppressors. By functioning as a dependence receptor, DCC induces apoptosis unless DCC is engaged by its ligand, netrin-1. Mehlen's group showed that inhibition of cell death by enforced expression of netrin-1 in mouse gastrointestinal tract leads to the spontaneous formation of hyperplastic and neoplastic lesions. 16, 17 Thus when their expression is ectopic or inappropriately regulated, dependence receptors can lead to cancer (as they become oncogenes or conditional tumor suppressors) or to severe developmental defects.
ALK is a dependence receptor
We recently demonstrated that ALK (anaplastic lymphoma kinase), a receptor tyrosine kinase of the insulin receptor superfamily, is a dependence receptor. 18 ALK was initially discovered as part of the NPM-ALK fusion protein, resulting from the t(2 ;5) translocation that is frequently associated with anaplastic large cell lymphomas (ALCL). 19, 20 It has been demonstrated that the NPM portion is responsible for the dimerization of the fusion protein leading to constitutive activation of the ALK kinase and to oncogenicity, 21 as shown for other fusion proteins involving tyrosine kinases such as BCR-ABL. 22 The native ALK protein, a type I transmembrane receptor, is mainly expressed in discrete regions of the developing central and peripheral nervous system, but is not present in hematopoietic cells. 23, 24 We had previously demonstrated that the oncogenic, constitutively kinase activated NPM-ALK protein was antiapoptotic when expressed in Jurkat lymphoblastic cells treated with cytotoxic drugs. 25 In order to approach the function of the wild type ALK receptor, which is still elusive, we expressed ALK in cell lines of either lymphoid or neuronal origin as models. Mutation at this site abolished both caspase cleavage and apoptosis enhancement. 18 Thus in the absence of ligand, the ALK receptor kinase is inactive and enhances apoptosis, whereas kinase activation, due to a ligand or constitutive as in NPM-ALK, decreases apoptosis. Unligated/kinase unactivated ALK receptor facilitates apoptosis via its own cleavage by caspases, a phenomenon allowing the exposure of a proapoptotic juxta-membrane intra-cellular domain ( Figure 1 ).
It has been shown that lymphocytes can survive limited caspase activation, 26 and that active caspase 3 was detected in ALK-positive ALCL tumors. 27 In the lymphoid Jurkat cells, we have observed that a certain degree of caspase activation was present both in parental and transfected cells (unpublished results). It is possible that ALK does not itself trigger apoptosis but acts as a sensitizer to whichever trigger is existant. Two signals would thus be necessary to enhance apoptosis. If the level of caspase activation reaches a certain threshold, depending on the cell itself and its environment, then we propose a model in which ALK is cleaved by caspase 3 (or possibly a related subfamily caspase member), exposing a proapoptotic region Page 6
and creating a positive feedback loop for apoptosis enhancement. This model could also apply to neuronal cells, where serum deprivation, a stimulus which per se does not induce cell death in murine immortalized neuroblasts, "pushes" ALK to induce cell death ( Figure 1 ).
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ALK is involved in development
Like several dependence receptors, 28 ALK is involved in neural development 23, 24 ( Table 1) and possibly morphogenesis, in spite of the lack of a lethal or abnormal phenotype in ALKknock-out mice (Morris, personal communication, and Duyster et al 29 ) . In situ hybridization analysis performed in rodents showed that the ALK mRNA is essentially and transiently expressed in specific regions of the central and peripheral nervous systems such as the thalamus, mid-brain, olfactory bulb and peripheral ganglia and that it is mainly localized in neuronal cells. 23, 24 Since ALK expression is maintained, albeit at a lower level, in the adult brain, it might play an important role both in the normal development and function of the nervous system. Interestingly, two recent papers analyzed the temporal spatial expression of the ALK receptor during the development of mice 30 and chicken, 31 showing that ALK is dynamically expressed on subsets of neurons of both the central and peripheral nervous system. It is noteworthy that the expression of the ALK transcript in spinal motor neurons overlaps temporally with the period of programmed cell death (which affects 50% of these neurons) in the chick embryo, suggesting that ALK could play a role in this phenomenon. 31 Our results showing a pro-death effect of ALK in both murine immortalized neuroblasts and in ex vivo primary neurons support the potential proapoptotic role of ALK under certain physiological conditions that remain to be determined.
A current difficulty encountered in elucidating the physiological role of ALK is that the ligands of ALK are still a matter of controversy, at least in mammals/vertebrates. Pleiotrophin (PTN) and midkine, two heparin-binding growth factors with pleiotrophic activities involved in normal development and tumor growth, 32 mediating neuronal circuit assembly in the Drosophila visual system. ALK is expressed and required in target neurons in the optic lobe, whereas jeb is primarily generated by photoreceptor axons and functions in the eye to control target selection of specific photoreceptor cell axons. 44 Interestingly, the authors pointed out that the level of neuronal cell death (measured by active caspase 3 expression) in the optic lobe medulla, an area in which ALK is expressed, increases in mutants lacking expression of jeb. Moreover, caspasedependent neuronal apoptosis dramatically decreases in mutants overexpressing jeb. 44 These results suggest ALK could play a role in the physiological negative selection of neurons shaping the optic lobe in the Drosophila nervous system, by favoring apoptosis in the absence of the ALK ligand. These in vivo observations provide a strong support to our classification of ALK as a dependence receptor. 18 Together, these findings suggest that jeb/ALK signaling helps photoreceptor cell axons to shape their environment for target neuron recognition. 44 It should also be noted that an ALK homologue has been identified in C. elegans. It is expressed at low levels in the nervous system and is proposed to regulate synapse differentiation at neuromuscular junctions. 45 Taken together, these studies (summarized in Table 1) show that in vertebrates, ALK is expressed early in development in the ectoderm that gives rise to the neural crest and its derivatives. Expression of ALK in the mesoderm is substantiated by studies showing its role in Drosophila gut development. [39] [40] [41] The observation that in chick, a distinct set of skeletal muscles of the limbs, together with motor neurons innervating these regions, are ALKpositive during embryo development, 31 suggests a possible role in neuromuscular synapse formation.
Inverse correlation between ALK kinase activation and ALK-mediated proapoptotic effect
The activation of receptor tyrosine kinases typically requires ligand-induced receptor oligomerization, which results in tyrosine autophosphorylation of the receptors. 46 We have shown that in the absence of ligand, ALK expressed by transfection in lymphoid or neuronal cells was not tyrosine phosphorylated (therefore the kinase was inactive) and exerted a proapoptotic effect. In the presence of a specific ligand (an agonist antibody) however, ALK became phosphorylated on tyrosine and the cells were partially rescued. 18 Thus there is an inverse correlation between the kinase activation and the proapoptotic activity of ALK.
Accordingly, the antiapoptotic activity of NPM-ALK in doxorubicin-treated Jurkat cells depended on the constitutive activation of the kinase. 25 Mutation of the ATP-binding site ("killing" the kinase) in NPM-ALK not only abrogated this antiapoptotic effect, but resulted in enhanced apoptosis, as efficiently as wild type ALK expression. 18 We noticed that the constitutively kinase-activated NPM-ALK chimeric protein, which contains the entire intra-cellular domain of ALK, was cleavable by caspase 3 in vitro, but was relatively resistant to cleavage after in vivo doxorubicin treatment of cells. The kinase-dead NPM-ALK mutant was more readily cleaved in vivo than its kinase-active counterpart, indicating that ALK phosphorylation partially prevents caspase cleavage, probably through a conformation change, and protects cells from apoptosis. . 47, 48 In order to see whether ALK could associate with proapoptotic effectors, we searched databases but were unable to find any death-like domain within the juxta-membrane intra-cytoplasmic sequence of ALK. The direct or indirect interaction of ALK with proapoptotic effector molecules will be the object of further studies.
In summary, we propose the following model for ALK positive and negative signaling (Figure 1 ). In the presence of ligand, the ALK receptor homodimerizes, activating its tyrosine kinase domain by transphosphorylation and mediating a decrease of apoptosis through various signaling pathways. In the absence of ligand, the ALK receptor is likely monomeric, the kinase is inactive and it enhances mitochondrial-dependent apoptosis : release of cytochrome c by the mitochondria, formation of the apoptosome associating cytochrome c with apoptotic protease activating factor 1 and procaspase 9, leading to caspase 9 and caspase 3 activation and eventually to apoptosis. 49 In conditions generating a sufficient level of activated caspases, ALK is cleaved by caspase 3 (or possibly a related subfamily caspase member), exposing a proapoptotic region within the juxta-membrane intra-cellular domain and creating a positive feedback loop for apoptosis enhancement.
ALK in cancer
ALK is involved in several chromosomal translocations or inversions, apart from the most common t(2;5) giving rise to the NPM-ALK fusion. Most of these X-ALK fusions are also found in ALCL, while a few can affect (though rarely) diffuse large B-cell lymphomas. Table 2 ). The oncogenic properties of some X-ALK proteins have been demonstrated, 52 sharing the same molecular mechanism, i.e., homodimerization of the chimera followed by constitutive kinase activation.
The wild type full size ALK protein has also been found expressed in human tumors, notably in neuroblastomas, in which ALK was generally not found tyrosine phosphorylated. 36, 53 These tumors, thought to originate from neural crest cells during embryonic development of the peripheral nervous system, occur in infants and young children, and often show spontaneous differentiation and regression. 54 It is noteworthy that spontaneous caspase activation observed in neuroblastomas correlates with a good prognosis. 55 Our observation of an apparent cleavage of ALK in two cell lines by western blotting (unpublished results) suggests that in vivo caspase activation could occur in neuroblastoma cells and favor ALK-dependent proapoptotic processes. The full length ALK is also found expressed in glioblastomas and melanomas, 36 that may originate from neural crest-derived cells. Whenever it has been studied, ALK tyrosine phosphorylation was not detected in primary tumors, but has been reported in rare cases for neuroblastoma 56 and possibly glioblastoma 57 cell lines. One may wonder whether it is a coincidence that ALK is involved in visceral and skeletal muscle development in Drosophila 42, 43 and chicken, 31 respectively, as well as in a subset of human rhabdomyosarcomas (skeletal muscle malignant tumors), 23 all these tissues having a mesodermal origin (Tables 1 and 2 ).
In summary, we have shown that inappropriate expression of ALK, in the absence of ligand and/or in the wrong cell setting, triggers or facilitates apoptosis. 18 On the other hand, mechanisms which inhibit apoptosis should enhance or promote tumorigenesis. Indeed when ALK is under its oncogenic form NPM-ALK, the proapoptotic effect of ALK due to its cleavage by caspases is balanced by the proliferative and pro-survival effect of the constitutively activated tyrosine kinase. In studies aimed at decreasing ALK expression in tumor cells by specific ribozymes 57 or siRNA, 56, 58 or inactivating ALK kinase using selective tyrosine kinase inhibitors, [59] [60] [61] it is interesting to note that the tumor cells rapidly die by apoptosis. We propose that apoptosis associated with inappropriately regulated ALK expression or ALK kinase inactivation could limit the tumorigenic effect of the ALK protooncogene. Our findings could have important implications in the therapy of ALK-positive tumors harboring the chimeric or wild type ALK protein. 
